This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Prognosis

Authoring team

Mortality from acute pancreatitis ranges from 1% in mild attacks to 50% in severe attacks to almost 100% in patients with multiple complications and poor prognostic signs (1).

Mild acute pancreatitis is generally treated with supportive care including pain control, intravenous fluids, and correction of electrolyte and metabolic abnormalities. A meta-analysis of eight trials revealed that enteral nutrition significantly reduced mortality, multiple organ failure, systemic infections, and the need for surgery compared with parenteral nutrition (2).

To prevent recurrence, the cause should be identified and eradicated. Cholecystectomy should be performed during the same admission if gallstones are suspected, as this is safer than delaying for 3 months. Alcohol should be screened by taking a careful history from the patient and relatives or close friends. Neither plasma gamma glutamyl transpeptidase nor blood alcohol are reliable indicators of abuse. Sadly, advice to abstain may not be heeded.

Most investigators do not believe that chronic pancreatitis results for acute pancreatitis unless complications such as pseudocysts or ductal strictures are present.

Reference:

  • Steer ML et al. Chronic pancreatitis. NEJM 1995;332: 1482-9.
  • Al-Omran M, Albalawi ZH, Tashkandi MF, Al-Ansary LA: Enteral versus parenteral nutrition for acute pancreatitis. Cochrane Database Syst Rev 2010, 20 , CD002837.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.